Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 14 years, with Q1 2022 value amounting to $29.5 million.

  • Lifecore Biomedical, Inc. \De\'s Shares Outstanding rose 54.22% to $29.5 million in Q1 2022 from the same period last year, while for Feb 2022 it was $29.5 million, marking a year-over-year increase of 54.22%. This contributed to the annual value of $29.3 million for FY2021, which is 37.3% up from last year.
  • According to the latest figures from Q1 2022, Lifecore Biomedical, Inc. \De\'s Shares Outstanding is $29.5 million, which was up 54.22% from $29.5 million recorded in Q4 2021.
  • Lifecore Biomedical, Inc. \De\'s 5-year Shares Outstanding high stood at $29.5 million for Q1 2022, and its period low was $27.6 million during Q1 2018.
  • Moreover, its 5-year median value for Shares Outstanding was $29.2 million (2020), whereas its average is $28.9 million.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Shares Outstanding skyrocketed by 526.58% in 2019 and then surged by 32.94% in 2020.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Shares Outstanding stood at $27.8 million in 2018, then rose by 4.96% to $29.2 million in 2019, then increased by 0.55% to $29.3 million in 2020, then increased by 0.54% to $29.5 million in 2021, then grew by 0.0% to $29.5 million in 2022.
  • Its Shares Outstanding was $29.5 million in Q1 2022, compared to $29.5 million in Q4 2021 and $29.5 million in Q3 2021.